MEG3 is significantly downregulated in primary human cancers such as lung cancer, liver cancer, gallbladder cancer, pituitary tumors and different cancer cell lines, and its expression level is significantly related with tumor grade, metastasis and poor prognosis [11]. Here, MEG3 is linked to neoplasm.